Clinical Trial

An Observational Study of Patients Living With Chronic Neurological Diseases

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
TARGET-NEURO is an observational research study to conduct a comprehensive review of outcomes for patients living with chronic neurological diseases: Alzheimer's disease and related dementia (ADRD), mild cognitive impairment (MCI), Parkinson's disease (PD), and multiple sclerosis (MS).
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-03-21; most recent amendment 2024-11-18.
Trial Details
NCT Number NCT05796037
Lead Sponsor Target PharmaSolutions, Inc.
Conditions Neurological Diseases or Conditions, Dementia of Alzheimer Type, Alzheimer Disease, Mild Cognitive Impairment, Parkinson Disease, Multiple Sclerosis
Enrollment 1,500,000 participants
Start Date 2025-03-31
Primary Completion 2038-12-31 (estimated)
Study Completion 2038-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-11-20